Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹59.98 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹59.98 Cr |
| Fresh Issue | ₹45.87 Cr |
| Offer for Sale | ₹11.10 Cr |
| Face Value | ₹10 Per Equity Share |
| Price Band | ₹105.00-111.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 544353 |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Unistone Capital Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 1,200 shares and in multiples thereof
Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies. This collaboration has enhanced the company's manufacturing, packaging, and distribution capabilities.
The product portfolio of the Company is divided into two categories, namely,
The company markets its products in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence before entering new markets to build a customer base.
The company develops products for dermatological disorders, including acne, fungal infections, anti-aging, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo.
As of September 30, 2024, the company has 84 employees on payroll.
Competitive Strength
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding of Working Capital Requirement of the company | 25.00 |
| 2 | Marketing and brand building activities | 5.00 |
| 3 | General Corporate Purposes | 14.24 |
| 4 | Issue expenses | 5.70 |
| Total | 49.93 |
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 28.89 | 18.98 | 12.39 | 6.59 |
| Total Income | 23.25 | 44.28 | 30.28 | 27.62 |
| Profit After Tax | 6.52 | 12.54 | 3.11 | 2.57 |
| NET Worth | 23.68 | 17.16 | 4.60 | 1.49 |
| Reserves and Surplus | 8.08 | 17.11 | 4.57 | 1.46 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2024 |
|---|---|
| ROE | 73.06% |
| ROCE | 94.16% |
| RoNW | 73.06% |
| PAT Margin | 28.53% |
| Price to Book Value | 10.09 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 8.04 | 6.52 |
| P/E (x) | 13.81 | 17.04 |
| Promoter Holding | 97% | 70.65% |
| Market Cap | ₹222.04 Cr. | |
